May 18, 2020 / 05:20PM GMT
Jon K. Snodgres - Repligen Corporation - CFO & Secretary
Hello, everyone.
Sondra S. Newman - Repligen Corporation - Global Head of IR
Hi, Jon. This is Sondra Newman. And I'm filling in for the moment for Dan, who I believe is tied up with a keynote speaker, but we do have some questions for Dan that I'll pass along to Jon. Dan, if you join at any time, feel free to just step in here.
So I think what is on everyone's mind and we're fielding a lot of questions about COVID and the impact on Repligen, the impact on our operations, the ability to keep manufacturing facilities open. And just generally, how this might be shifting demand for our products? So very -- in a very big picture, Jon, could you comment on how things have changed at Repligen with the pandemic?
Jon K. Snodgres - Repligen Corporation - CFO & Secretary
Yes. Sure, Sondra, shall I open up with the -- with an overview, a little bit of an overview of the company, and we can jump into the questions?
Sondra S. Newman
Repligen Corp at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers